Increasing geriatric
population is expected to drive the growth of Europediagnostics market
According
to TechSci Research report, “Europe Diagnostics Market By Product Type (Reagents, Instruments, Software
& Services), By Type of Test (Lipid Panel, Metabolic Panel, Infectious
Disease Testing, Others), By Technique (Immunodiagnostics, Molecular
Diagnostics, Tissue Diagnostics, Clinical Techniques, Others), By Usability
(Reusable v/s Disposable), By Application (Infectious Diseases, Cancer, Cardiac
Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal
Diseases, Others), By End User (Hospitals & Clinics, Diagnostic Centers,
Point-of-Care Testing Centers, Private or Commercial Laboratories, Others), By Country,
Forecast & Opportunities, 2025”, the Europediagnosticsmarket is expected to grow at an
impressive rateduring the forecast periodon account of the increasing number of
diagnostic centers, laboratories and point of care testing centers.
Additionally, increasing lab automation and adoption of advanced technologies
in the healthcare industry is further expected to foster the market growth
through 2025. Furthermore, increasing investments on advanced healthcare
infrastructure coupled with new diagnostic products, instruments or testing
techniques launches by the major players operating in the market, is expected
to create lucrative opportunities for the market growth over the next few
years. Besides, associated benefits such as early disease detection, disease
management, ease of procurement of samples, quick results delivery,
availability of affordable tests, lesser pain, among others are further
expected to fuel the market growth during the forecast period. However,
stringent regulations pertaining to approval of diagnostic products, kits,
reagents, instruments, among others might restrict the market growth through
2025. Also, slow reimbursement rate might further hamper the market growth.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on
"EuropeDiagnostics
Market"
The Europediagnosticsmarket is segmented based on product type, type of
test, technique, usability, application, end user, company and region. Based on
product type, the market can be categorized into reagents, instruments and
software & services.Among these, the instrument segment is expected to
register significant growth in the market owing to the increasing demand for
advanced medical instruments and equipment, which deliver accurate and reliable
diagnostic test results.Based on technology, the market can be categorized into
immunodiagnostics, molecular diagnostics, tissue diagnostics, clinical
techniques and others. Out of these, the molecular diagnostics market is
expected to dominate the market owing to the increasing application of
molecular diagnostic techniques in point-of-care testing and pharmacogenetics.
Additionally, increasing number of blood tests being performed on account of
growing prevalence of chronic diseases is further driving the segmental
growth.Based on end user, the market can be fragmented into hospitals &
clinics, diagnostic centers, point-of-care testing centers, private or
commercial laboratories and others. Here, the hospitals segment is expected to
dominate the market owing to the increasing volumes of tests being conducted in
hospitals. However, the point-of-care testing centers are expected to witness
significant growth in the market owing to the increasing geriatric population
suffering from various diseases. Additionally, these tests deliver immediate
results and help in improving overall patient care.
Roche Diagnostics, Alere, Inc., Abbott Laboratories, Inc., Hologic, Inc.
(Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation,
Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., Siemens Healthcare GmbH
and othersare some of the leading players operating in Europediagnosticsmarket.The
companies operating in the market are using organic strategies such as product
launches, mergers and collaborations to boost their share.
Customers can also
request for 10% free customization on this report.
“European countries have a highly
regulated healthcare infrastructure owing to the presence of major healthcare
and pharmaceutical companies in the region. The Europe diagnostics market is
expected to grow at a formidable rate owing to the increasing awareness regarding
preventive healthcare among the population. Additionally, supportive government
policies and schemes for promoting better healthcare and disease prevention are
further expected to create lucrative opportunities for the market growth
through 2025.”said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“EuropeDiagnosticsMarket By
Product Type (Reagents, Instruments, Software & Services), By Type of Test
(Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others), By
Technique (Immunodiagnostics, Molecular Diagnostics, Tissue Diagnostics,
Clinical Techniques, Others), By Usability (Reusable v/s Disposable), By
Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System
Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End
User (Hospitals & Clinics, Diagnostic Centers, Point-of-Care Testing
Centers, Private or Commercial Laboratories, Others), By Country, Forecast
& Opportunities, 2025”,
has evaluated the future growth potential of Europediagnosticsmarketand
provides statistics &information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in Europediagnostics market.
Global Coronavirus Diagnostics Market
By Type of Test (Molecular v/s Serology), By User (Single v/s Multiple), By
Full Test Time (Less Than 60 Minutes, 1 Hour - 12 Hours, 13 Hours - 24 Hours,
More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or
Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast
& Opportunities, 2025
Global Clinical Diagnostics Market By
Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing,
Others), By Product (Instruments, Reagents, Assays and Kits, Software), By
Application (Infectious Disease (COVID-19, Sepsis, HIV , Others), Cardiology,
Cancer), By Region, Competition, Forecast & Opportunities, 2025
No comments:
Post a Comment